LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	NVP-AEW541	0.04	uM	LJP5	2	E18	72	hr	1334	4135	3970	1.0413	1.0622
BT-20	PIK-93	0.04	uM	LJP5	3	K18	72	hr	1334	4424	3970	1.1141	1.1719
BT-20	Barasertib	0.04	uM	LJP5	1	D12	72	hr	1334	3039	3970	0.7653	0.6465
BT-20	NVP-AEW541	0.04	uM	LJP5	1	E18	72	hr	1334	3946	3970	0.9937	0.9906
BT-20	SB590885	0.04	uM	LJP5	2	L18	72	hr	1334	4116	3970	1.0365	1.0550
BT-20	PIK-93	0.04	uM	LJP5	2	K18	72	hr	1334	3925	3970	0.9884	0.9826
BT-20	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	1334	3267	3970	0.8227	0.7330
BT-20	AZD8330	0.04	uM	LJP5	3	G24	72	hr	1334	3080	3970	0.7756	0.6621
BT-20	Barasertib	0.04	uM	LJP5	3	D12	72	hr	1334	3767	3970	0.9487	0.9227
BT-20	GDC-0980	0.04	uM	LJP5	3	K24	72	hr	1334	2402	3970	0.6049	0.4049
BT-20	NVP-AEW541	0.04	uM	LJP5	3	E18	72	hr	1334	4326	3970	1.0894	1.1347
BT-20	SB590885	0.04	uM	LJP5	1	L18	72	hr	1334	4182	3970	1.0532	1.0801
BT-20	SB590885	0.04	uM	LJP5	3	L18	72	hr	1334	4414	3970	1.1116	1.1681
BT-20	PIK-93	0.04	uM	LJP5	1	K18	72	hr	1334	4052	3970	1.0204	1.0308
BT-20	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	1334	4447	3970	1.1199	1.1806
BT-20	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	1334	3923	3970	0.9879	0.9818
BT-20	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	1334	4014	3970	1.0109	1.0163
BT-20	AZD8330	0.04	uM	LJP5	2	G24	72	hr	1334	3206	3970	0.8074	0.7099
BT-20	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	1334	3559	3970	0.8963	0.8438
BT-20	Barasertib	0.04	uM	LJP5	2	D12	72	hr	1334	3228	3970	0.8129	0.7182
BT-20	GDC-0980	0.04	uM	LJP5	1	K24	72	hr	1334	2438	3970	0.6140	0.4185
BT-20	GDC-0980	0.04	uM	LJP5	2	K24	72	hr	1334	2370	3970	0.5968	0.3927
BT-20	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	1334	3708	3970	0.9338	0.9003
BT-20	Alpelisib	0.04	uM	LJP5	1	N06	72	hr	1334	4050	3970	1.0199	1.0300
BT-20	AZD8330	0.04	uM	LJP5	1	G24	72	hr	1334	2916	3970	0.7343	0.5998

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)